Recent performance shows that the healthcare sector has risen about 15% year‑to‑date, positioning it as a defensive haven during volatile markets. Among its major constituents, CVS Health Corp. exhibits a compelling risk‑reward profile. The one‑year daily chart indicates a support zone between $82 and $86; traders are advised to remain long above this range and to exit or reassess positions below it. Momentum indicators, including a bullish MACD signal, suggest upward pressure, with price targets first toward $99, reflecting the earnings‑gap, and potentially to $105 if momentum persists, approaching 52‑week highs. A five‑year weekly chart reinforces a longer‑term uptrend, with projected targets of $110, a likely retest of resistance, and a possible breakout to $150 within 6‑9 months. Key risk management levels remain $82‑$86 across both time frames. The long‑term stochastic signals a buy, while other momentum metrics remain neutral.
